1Theriault RL, Lipton A, Hortobagyi CN, et al. Pamidronate reduces skeletal, morbidiy in women with advanced breast cancer and cytic bone lesion:a randomized, placebo-contrdled trial protocol 18 Areia Breast Cancer Study Group[J]. J Clin Oncol, 1999,17(3) :846 - 854.
2Fitto A Mc,Tavish D. Pamidronate:A review of its pharm acoloical properties and therapcutic efficacy[J]. Resorptive Bone Drugs,1991,14:289 - 318.
3Paterson AH. Should bisphonates be stand therapy for bone pain[J]. Suppo Care Cancer,1997,5(3) :455.
4Lipton A, Berenson JR. Bisphosphonate treatment of lyticbone metastaswas[J]. Drug Aging, 1999,14(4) :24 - 246.
5Rosen CJ, Kessnich CR. Comparative clinical pharmacology and therapeutic use of bispbonates in metabolic bone diseases[J]. Drug,1996,51 (4) :537 - 551.
